283 related articles for article (PubMed ID: 15096701)
1. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease.
Praticò D; Sung S
J Alzheimers Dis; 2004 Apr; 6(2):171-5. PubMed ID: 15096701
[TBL] [Abstract][Full Text] [Related]
2. The neurobiology of isoprostanes and Alzheimer's disease.
Praticò D
Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
[TBL] [Abstract][Full Text] [Related]
3. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and oxygen radicals: new insights.
Praticò D
Biochem Pharmacol; 2002 Feb; 63(4):563-7. PubMed ID: 11992623
[TBL] [Abstract][Full Text] [Related]
5. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
7. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder.
Sultana R; Mecocci P; Mangialasche F; Cecchetti R; Baglioni M; Butterfield DA
J Alzheimers Dis; 2011; 24(1):77-84. PubMed ID: 21383494
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation in Alzheimer's disease: emphasis on metal-mediated neurotoxicity.
Obulesu M; Venu R; Somashekhar R
Acta Neurol Scand; 2011 Nov; 124(5):295-301. PubMed ID: 21303349
[TBL] [Abstract][Full Text] [Related]
9. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
Praticò D; MY Lee V; Trojanowski JQ; Rokach J; Fitzgerald GA
FASEB J; 1998 Dec; 12(15):1777-83. PubMed ID: 9837868
[TBL] [Abstract][Full Text] [Related]
10. Oxidative alterations in Alzheimer's disease.
Markesbery WR; Carney JM
Brain Pathol; 1999 Jan; 9(1):133-46. PubMed ID: 9989456
[TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
12. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
[TBL] [Abstract][Full Text] [Related]
13. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
[TBL] [Abstract][Full Text] [Related]
14. Altered mitochondrial membrane fluidity in AD brain.
Mecocci P; Cherubini A; Beal MF; Cecchetti R; Chionne F; Polidori MC; Romano G; Senin U
Neurosci Lett; 1996 Mar; 207(2):129-32. PubMed ID: 8731438
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
Jakaria M; Belaidi AA; Bush AI; Ayton S
J Neurochem; 2021 Dec; 159(5):804-825. PubMed ID: 34553778
[TBL] [Abstract][Full Text] [Related]
16. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
17. 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress.
Praticò D; Zhukareva V; Yao Y; Uryu K; Funk CD; Lawson JA; Trojanowski JQ; Lee VM
Am J Pathol; 2004 May; 164(5):1655-62. PubMed ID: 15111312
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
[TBL] [Abstract][Full Text] [Related]
19. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
20. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
